Reuters -- The recall of some versions of Matrixx Initiatives’ (MTXX.O) widely used Zicam cold remedy products could cost the company as much as $10 million, company officials said on Thursday.
Reuters -- The recall of some versions of Matrixx Initiatives’ (MTXX.O) widely used Zicam cold remedy products could cost the company as much as $10 million, company officials said on Thursday.
